14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ANTH
Delisted

Anthera Pharmaceuticals Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.000001
+0 (+0%)
At Close: May 27, 2022
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Sep 25, 2018 $0.0771 $0.0876 $0.0736 $0.0805 121 578
Sep 24, 2018 $0.0730 $0.0840 $0.0730 $0.0790 46 889
Sep 21, 2018 $0.0750 $0.0849 $0.0740 $0.0770 65 238
Sep 20, 2018 $0.0819 $0.0840 $0.0750 $0.0756 165 552
Sep 19, 2018 $0.0728 $0.0850 $0.0715 $0.0785 90 918
Sep 18, 2018 $0.0700 $0.0845 $0.0700 $0.0845 121 723
Sep 17, 2018 $0.0700 $0.0750 $0.0700 $0.0750 63 770
Sep 14, 2018 $0.0700 $0.0750 $0.0700 $0.0750 21 435
Sep 13, 2018 $0.0720 $0.0798 $0.0700 $0.0750 138 625
Sep 12, 2018 $0.0740 $0.0799 $0.0720 $0.0786 88 659
Sep 11, 2018 $0.0720 $0.0783 $0.0720 $0.0740 32 160
Sep 10, 2018 $0.0850 $0.0850 $0.0720 $0.0738 48 219
Sep 07, 2018 $0.0770 $0.0850 $0.0770 $0.0815 54 275
Sep 06, 2018 $0.0721 $0.0845 $0.0721 $0.0770 45 194
Sep 05, 2018 $0.0723 $0.0845 $0.0723 $0.0787 57 297
Sep 04, 2018 $0.0700 $0.0848 $0.0700 $0.0762 52 017
Aug 31, 2018 $0.0740 $0.0850 $0.0700 $0.0776 56 422
Aug 30, 2018 $0.0720 $0.0780 $0.0700 $0.0710 184 116
Aug 29, 2018 $0.0850 $0.0850 $0.0720 $0.0721 72 060
Aug 28, 2018 $0.0745 $0.0900 $0.0700 $0.0771 213 812
Aug 27, 2018 $0.0800 $0.0900 $0.0750 $0.0800 109 608
Aug 24, 2018 $0.0835 $0.0950 $0.0800 $0.0850 73 362
Aug 23, 2018 $0.0850 $0.0900 $0.0720 $0.0900 227 832
Aug 22, 2018 $0.0905 $0.0950 $0.0850 $0.0950 45 613
Aug 21, 2018 $0.0880 $0.0950 $0.0820 $0.0905 70 541
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT